Previous 10 | Next 10 |
SOLANA BEACH, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will release financial results for its 2023 first quarte...
SOLANA BEACH, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced it will exhibit at the 2023 American Association of Neurological...
SOLANA BEACH, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced an exclusive worldwide agreement with NE Scientific, LLC, a lead...
2023-04-17 08:24:53 ET Marpai ( MRAI ) -41% after pricing equity offering. Petros Pharmaceuticals ( PTPI ) -24% . SAI.TECH Global Corporation ( SAI ) -18% . Near Intelligence ( NIR ) -20% . ClearPoint Neuro ( CLPT ) -15%. Sta...
SOLANA BEACH, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced successful registration of its Neuro Navigation portfolio with t...
SOLANA BEACH, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced further expansion of its worldwide license and research agreemen...
2023-03-29 07:40:28 ET Medical device company ClearPoint Neuro ( NASDAQ: CLPT ) has signed an exclusive multi-year licensing agreement with UC San Francisco to develop and commercialize a brain-focused cellular delivery device. The intracerebral device is designed to help ...
SOLANA BEACH, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced an exclusive multi-year licensing agreement of intellectual prop...
Shares of ClearPoint Neuro ( NASDAQ: CLPT ) on Thursday slumped 9.6% to $8.22 in late afternoon trading. The company after hours on Wednesday reported a 21% Y/Y rise in Q4 revenue to $5.2M. FY revenue of $20.55M missed estimates by $0.03M , while FY GAAP EPS of -$0.68 be...
ClearPoint Neuro, Inc. (CLPT) Q4 2022 Earnings Conference Call March 01, 2023 04:30 PM ET Company Participants Joe Burnett - CEO Danilo D’Alessandro - CFO Conference Call Participants Frank Takkinen - Lake Street Capital Markets Neil Chatterji - B. R...
News, Short Squeeze, Breakout and More Instantly...
ClearPoint Neuro, Inc. Company Name:
CLPT Stock Symbol:
NASDAQ Market:
ClearPoint Neuro, Inc. Website:
SOLANA BEACH, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its ...
2024-07-15 17:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...